Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EI24 pseudogene 6 (abbreviated as EI24P6) is identified as a pseudogene of the EI24 gene, which encodes a putative tumor suppressor implicated in autophagy, apoptosis, and cancer suppression[1][3]. There are several EI24-related pseudogenes on different chromosomes, but EI24P6 is not believed to encode a functional protein or have autonomous molecular or therapeutic relevance. Pseudogenes like EI24P6 generally arise through genomic duplication or retrotransposition and are not directly involved in biological processes or targeted by drugs. All functional research and clinical relevance pertains to the EI24 gene itself, not its pseudogenes[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EI24 pseudogene 6 (EI24P6).